Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Zymeworks Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Zymeworks Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Zymeworks Raises USD61.5 Million in Series A Financing 12
Zymeworks Secures USD23.98 Million in Venture Funding 14
Zymeworks Raises USD4 Million in Venture Financing 15
Zymeworks Raises US$11 Million In Venture Financing 16
Partnerships 17
ImClone Systems Enters Licensing Agreement with Zymeworks 17
Zymeworks Enters into Research Agreement with University of Victoria and BC Cancer Agency 18
Applied BioMath Extends Partnership with Zymeworks 19
Zymeworks Enters into Agreement with Kairos Therapeutics 20
ProBioGen Enters into Agreement with Zymeworks 21
Zymeworks Enters into Research Agreement with University of California, Los Angeles 22
National Research Council Enters into Co-Development Agreement with Zymeworks for Cancer 23
Licensing Agreements 24
Daiichi Sankyo Enters into Licensing Agreement with Zymeworks 24
Janssen Biotech Enters into Licensing Agreement with Zymeworks 25
Daiichi Sankyo Enters into Licensing Agreement with Zymeworks 26
Zymeworks Enters into Licensing Agreement with Daiichi Sankyo 27
Zymeworks Enters into Licensing Agreement with Innovative Targeting Solutions 28
Zymeworks Enters into Licensing Agreement with GlaxoSmithKline 29
Zymeworks Enters into Licensing Agreement with GlaxoSmithKline 30
Zymeworks Enters into Licensing Agreement with Selexis 31
Celgene Exercises Licensing Agreement with Zymeworks for Bi-Specific Antibody 32
Zymeworks Extends Licensing Agreement with Merck 33
Zymeworks Expands Licensing Agreement with Eli Lilly 34
Zymeworks Enters into Licensing with Agreement with Lilly 35
Equity Offering 36
Zymeworks Raises USD97.8 Million in Public Offering of Share 36
Zymeworks Announces Underwriters Exercise of Over-Allotment Option in IPO 38
Zymeworks Raises USD1.8 Million in Private Placement of Shares 40
Zymeworks Raises USD8.6 Million in Private Placement of Shares 41
Zymeworks Completes Private Placement of Shares for USD17.3 Million 42
Acquisition 43
Zymeworks Acquires Remaining 80.01% Stake in Kairos Therapeutics for USD24.8 Million 43
Zymeworks Acquires 19.99% Stake in Kairos Therapeutics for USD3.6 Million 44
Zymeworks Inc – Key Competitors 45
Zymeworks Inc – Key Employees 46
Zymeworks Inc – Locations And Subsidiaries 47
Head Office 47
Other Locations & Subsidiaries 47
Recent Developments 48
Financial Announcements 48
Aug 01, 2018: Zymeworks reports financial results for the second quarter of 2018 48
May 01, 2018: Zymeworks Reports 2018 First Quarter Financial Results 50
Mar 14, 2018: Zymeworks Reports 2017 Year-End Financial Results 51
Nov 08, 2017: Zymeworks Reports Third Quarter 2017 Financial Results and Provides Business Update 52
Aug 08, 2017: Zymeworks Reports Second Quarter 2017 Financial Results 53
May 15, 2017: Zymeworks Reports First Quarter 2017 Financial Results 54
Corporate Communications 55
Sep 19, 2018: Zymeworks appoints Anthony Polverino as executive vice president of early development and Chief Scientific Officer 55
Jun 07, 2018: Zymeworks appoints Ali Tehrani and Nick Bedford as board directors 56
Feb 14, 2017: Zymeworks Appoints Dr. Kenneth Hillan and Hollings Renton to its Board of Directors 57
Product News 58
Jan 05, 2017: Zymeworks Announces the Successful Achievement of a Research Milestone with Lilly in Bispecific Antibody Collaboration 58
Clinical Trials 59
Mar 14, 2018: Zymeworks Advances Clinical Candidate Incorporating Technology from Kairos Acquisition 59
Appendix 60
Methodology 60
About GlobalData 60
Contact Us 60
Disclaimer 60
Zymeworks Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Zymeworks Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Zymeworks Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Zymeworks Raises USD61.5 Million in Series A Financing 12
Zymeworks Secures USD23.98 Million in Venture Funding 14
Zymeworks Raises USD4 Million in Venture Financing 15
Zymeworks Raises US$11 Million In Venture Financing 16
ImClone Systems Enters Licensing Agreement with Zymeworks 17
Zymeworks Enters into Research Agreement with University of Victoria and BC Cancer Agency 18
Applied BioMath Extends Partnership with Zymeworks 19
Zymeworks Enters into Agreement with Kairos Therapeutics 20
ProBioGen Enters into Agreement with Zymeworks 21
Zymeworks Enters into Research Agreement with University of California, Los Angeles 22
National Research Council Enters into Co-Development Agreement with Zymeworks for Cancer 23
Daiichi Sankyo Enters into Licensing Agreement with Zymeworks 24
Janssen Biotech Enters into Licensing Agreement with Zymeworks 25
Daiichi Sankyo Enters into Licensing Agreement with Zymeworks 26
Zymeworks Enters into Licensing Agreement with Daiichi Sankyo 27
Zymeworks Enters into Licensing Agreement with Innovative Targeting Solutions 28
Zymeworks Enters into Licensing Agreement with GlaxoSmithKline 29
Zymeworks Enters into Licensing Agreement with GlaxoSmithKline 30
Zymeworks Enters into Licensing Agreement with Selexis 31
Celgene Exercises Licensing Agreement with Zymeworks for Bi-Specific Antibody 32
Zymeworks Extends Licensing Agreement with Merck 33
Zymeworks Expands Licensing Agreement with Eli Lilly 34
Zymeworks Enters into Licensing with Agreement with Lilly 35
Zymeworks Raises USD97.8 Million in Public Offering of Share 36
Zymeworks Announces Underwriters Exercise of Over-Allotment Option in IPO 38
Zymeworks Raises USD1.8 Million in Private Placement of Shares 40
Zymeworks Raises USD8.6 Million in Private Placement of Shares 41
Zymeworks Completes Private Placement of Shares for USD17.3 Million 42
Zymeworks Acquires Remaining 80.01% Stake in Kairos Therapeutics for USD24.8 Million 43
Zymeworks Acquires 19.99% Stake in Kairos Therapeutics for USD3.6 Million 44
Zymeworks Inc, Key Competitors 45
Zymeworks Inc, Key Employees 46
Zymeworks Inc, Subsidiaries 47
List of Figures
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9